Compare · CHE vs PIII
CHE vs PIII
Side-by-side comparison of Chemed Corp (CHE) and P3 Health Partners Inc. (PIII): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHE and PIII operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $6.74B, about 224.1x PIII ($30.1M).
- CHE has been more active in the news (4 items in the past 4 weeks vs 2 for PIII).
- CHE has more recent analyst coverage (7 ratings vs 5 for PIII).
- Company
- Chemed Corp
- P3 Health Partners Inc.
- Price
- -
- -
- Market cap
- $6.74B
- $30.1M
- 1M return
- -
- -47.79%
- 1Y return
- -
- -51.78%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 4
- 2
- Recent ratings
- 7
- 5
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
P3 Health Partners Inc.
P3 Health Partners Inc. provides primary health care services. The company offers clinical operations and population health management services, as well as provides senior wellness centers. The company is based in Henderson, Nevada.
Latest CHE
- Executive vice president Lee Spencer S exercised 12,099 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 11,160 units of Capital Stock, increasing direct ownership by 7% to 14,851 units (SEC Form 4)
- Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28
- President and CEO Mcnamara Kevin J sold $1,026,900 worth of Capital Stock (2,000 units at $513.45), decreasing direct ownership by 3% to 66,418 units (SEC Form 4)
- Vice president Hutton Thomas C exercised 4,629 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 4,270 units of Capital Stock, increasing direct ownership by 1% to 32,840 units (SEC Form 4)
- UBS initiated coverage on Chemed with a new price target
- President and CEO Mcnamara Kevin J sold $1,002,800 worth of Capital Stock (2,000 units at $501.40), decreasing direct ownership by 3% to 68,418 units (SEC Form 4)
- Roto-Rooter Buys Largest Franchisee Territory
- Chemed Corporation to Present at the Jefferies 2026 Healthcare Services Conference
- Executive vice president Lee Spencer S sold $541,040 worth of Capital Stock (1,000 units at $541.04), decreasing direct ownership by 7% to 13,912 units (SEC Form 4)
- President and CEO Mcnamara Kevin J sold $1,082,320 worth of Capital Stock (2,000 units at $541.16), decreasing direct ownership by 3% to 70,418 units (SEC Form 4)
Latest PIII
- SEC Form S-3 filed by P3 Health Partners Inc.
- P3 Health Partners Inc. Announces Appointment of Chief Clinical Officer
- P3 Health Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- Large owner Hudson Vegas Investment Spv, Llc converted options into 100,000 shares and disposed of 100,000 units of Class V Common Stock (SEC Form 4)
- Large owner Hudson Vegas Investment Spv, Llc sold $823,927 worth of shares (50,000 units at $16.48) (SEC Form 4)
- SEC Form 10-Q filed by P3 Health Partners Inc.
- P3 Health Partners Announces Second Quarter 2026 Results
- P3 Health Partners Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call
- P3 Health Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits